Should I shadow China Jo shareholders?

China Jo Average Equity is expected to decrease significantly based on the last few years of reporting. The past year's Average Equity was at 15.1 Million. The current year Enterprise Value is expected to grow to about 100 M, whereas Earnings before Tax are expected to decline to (768.6 K). China Jo Jo is scheduled to anounce its earnings tomorrow. While many traders are getting carried away by overanalyzing retail, it is reasonable to digest China Jo Jo against current market trends. We will cover the possibilities of making China Jo into a steady grower in August. China Jo Jo follows the market closely. The returns on the market and returns on China Jo appear slightly-related for the last few months. Sound fundamental drivers of the firm may indicate signs of shorter-term price drift for shareholders. China Jo Jo Piotroski F Score is 2 - Frail.
Published over a year ago
View all stories for China Jo | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Raphi Shpitalnik

The company has a beta of -0.5368. Let's try to break down what China's beta means in this case. As returns on the market increase, China Jo returns are expected to increase less than the market. However, during the bear market, the loss on holding China Jo will be expected to be smaller as well. The beta indicator helps investors understand whether China Jo moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if China deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns.
Using predictive technical analysis, we can analyze different prices and returns patterns and diagnose historical swings to determine the real value of China Jo Jo Drugstores. In general, sophisticated investors focus on analyzing China Jo stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build China Jo's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of China Jo's intrinsic value. In addition to deriving basic predictive indicators for China Jo, many experienced traders also check how macroeconomic factors affect China Jo price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of China Jo's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of China Jo in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as China Jo. Your research has to be compared to or analyzed against China Jo's peers to derive any actionable benefits. When done correctly, China Jo's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in China Jo-Jo Drugstores.

How does China Stands against Peers?

Analyzing China Jo competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to China Jo across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be. Check out China Jo Competition Details

Scrutinizing China Jo - a closer look

China Jo Jo reported previous year revenue of 113.45 M. Net Loss for the year was (234.4 K) with profit before overhead, payroll, taxes, and interest of 25.11 M. China Jo Earnings Before Interest Taxes and Depreciation Amortization USD is rather stable at the moment. China Jo is selling for under 1.39. That is 2.96% increase. Today the lowest price is 1.34.

Over 3 percent ascent for China Jo today. What does it mean for shareholders?

China Jo latest coefficient of variation ascents over 11133.97. China Jo Jo is showing large volatility of returns over the selected time horizon. We encourage all investors to investigate this asset further to make sure related market timing strategies are aligned with all the expectations about China Jo implied risk.

Our Final Take On Investing in China Jo

While many of the other players under pharmaceutical retailers industry are still a little expensive, even after the recent corrections, China Jo may offer a potential longer-term growth to investors. To conclude, as of 5th of July 2020, we believe China Jo is currently overvalued. It follows the market closely and projects below average odds of financial distress in the next two years. Our ongoing 30 days advice on the firm is Strong Sell. With a less-than optimistic outlook for your 30 days horizon, it may be a good time to short some or all of your China Jo holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to China Jo.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of China Jo Jo Drugstores. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com